Three years after its initial FDA approval, Roche has made up for an early disadvantage with its blood cancer drug Lunsumio ...

President, Academy of Health Professionals, Ravi Kumudesh, yesterday (22), alleged that the National Medicines Regulatory Authority’s (NMRA) decision to suspend several batches of Ondansetron ...

Decades of research show syringe programs are extremely effective at preventing infectious disease among intravenous drug ...

United did not need to see Livramento limp out of the Carabao Cup win over Fulham, especially has he has only just returned ...

Genentech, a member of the Roche Group, said the U.S. Food and Drug Administration approved its treatment for follicular lymphoma.

The silence at Florida State Prison was palpable Thursday evening as the curtain to the death chamber opened, showing Frank ...

President Anura Kumara Dissanayake stated that national progress cannot be achieved through suspicion and mistrust of one another, but only when everyone fulfills the responsibilities entrusted to ...

This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industryLOS ANGELES--(BUSINESS WIRE)--$NAGE ...

For nearly a year, a professor taught nursing fundamentals to students at Eagle Gate College in Boise. He supervised them ...